E. Garnova

Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestine

A. Murphy, G. Yancopoulos, W. Olson, 2020, Science Immunology.

Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy

C. Siao, L. Macdonald, A. Murphy, 2020, Science Translational Medicine.

Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice

A. Murphy, I. Lowy, G. Thurston, 2017, Molecular Cancer Therapeutics.

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

M. Retter, G. Thurston, P. Duramad, 2019, Science Translational Medicine.